UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands

PloS one, 2018-02, Vol.13 (2), p.e0192640-e0192640

2018

Volltextzugriff (PDF)

Safety and immunogenicity of an MF59® -adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age

Vaccine, 2015-01, Vol.33 (1), p.174-181

2015

Volltextzugriff (PDF)

Varicella vaccination in Europe - taking the practical approach

BMC medicine, 2009-05, Vol.7 (26), p.26-26, Article 26

2009

Volltextzugriff (PDF)

Adverse events and association with age, sex and immunological parameters of Q fever vaccination in patients at risk for chronic Q fever in the Netherlands 2011

Vaccine, 2014-11, Vol.32 (49), p.6622-6630

2014

Volltextzugriff (PDF)

Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax®) in individuals aged ≥ 70 years: A randomized study of a single dose vs. two different two-dose schedules

Human vaccines & immunotherapeutics, 2013-04, Vol.9 (4), p.858-864

2013

Volltextzugriff (PDF)

The epidemiology of varicella and herpes zoster in The Netherlands: Implications for varicella zoster virus vaccination

Vaccine, 2006-05, Vol.24 (18), p.3946-3952

2006

Volltextzugriff (PDF)

Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children

Human vaccines & immunotherapeutics, 2015-02, Vol.11 (2), p.358-376

2015

Volltextzugriff (PDF)

Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial

BMC infectious diseases, 2013-07, Vol.13 (1), p.348-348, Article 348

2013

Volltextzugriff (PDF)

Immunogenicity and tolerability of an MF59-adjuvanted, egg-derived, A/H1N1 pandemic influenza vaccine in children 6-35 months of age

The Pediatric infectious disease journal, 2014-12, Vol.33 (12), p.e320-e329

2014

Volltextzugriff (PDF)

Safety of a 2-dose regimen of a combined measles, mumps, rubella and varicella live vaccine manufactured with recombinant human albumin

The Pediatric infectious disease journal, 2012-11, Vol.31 (11), p.1166-1172

2012

Volltextzugriff (PDF)

Implementation of a Q fever vaccination program for high-risk patients in the Netherlands

Vaccine, 2013-05, Vol.31 (23), p.2617-2622

2013

Volltextzugriff (PDF)

Specific Interferon γ Detection for the Diagnosis of Previous Q Fever

Clinical infectious diseases, 2013-06, Vol.56 (12), p.1742-1751

2013

Volltextzugriff (PDF)

Immunization of Early Adolescent Females with Human Papillomavirus Type 16 and 18 L1 Virus-Like Particle Vaccine Containing AS04 Adjuvant

Journal of adolescent health, 2007-06, Vol.40 (6), p.564-571

2007

Volltextzugriff (PDF)

Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2–3 and 7–8 years of age

Vaccine, 2000-02, Vol.18 (15), p.1456-1466

2000

Volltextzugriff (PDF)

Elevated Immune Response Among Children 4 Years of Age With Pronounced Local Adverse Events After the Fifth Diphtheria, Tetanus, Acellular Pertussis Vaccination

The Pediatric infectious disease journal, 2017-09, Vol.36 (9), p.e223-e229

2017

Volltextzugriff (PDF)

Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial

Vaccine, 2008-05, Vol.26 (19), p.2378-2388

2008

Volltextzugriff (PDF)

The burden of varicella from a parent's perspective and its societal impact in The Netherlands: an Internet survey

BMC infectious diseases, 2011-11, Vol.11 (1), p.320-320, Article 320

2011

Volltextzugriff (PDF)

In Memoriam: Prof. Dr. J.M.J.J. Vossen (1937–2019)

Journal of clinical immunology, 2019-08, Vol.39 (6), p.530-531

2019

Volltextzugriff (PDF)

A tailor‐made approach for causality assessment for ADR reports on drugs and vaccines

Pharmacoepidemiology and drug safety, 2019-04, Vol.28 (4), p.544-550

2019

Volltextzugriff (PDF)

Prevention of Meningococcal Serogroup B Infections in Children: A Protein-Based Vaccine Induces Immunologic Memory

The Journal of infectious diseases, 2001-07, Vol.184 (1), p.98-102

2001

Volltextzugriff (PDF)

Reactogenicity of acellular pertussis vaccine in 4-year-olds in The Netherlands

Vaccine, 2004-09, Vol.22 (25), p.3256-3257

2004

Volltextzugriff (PDF)

Vaccine-Induced Antibody Responses as Parameters of the Influence of Endogenous and Environmental Factors

Environmental health perspectives, 2001-08, Vol.109 (8), p.757-764

2001

Volltextzugriff (PDF)

'Without industry no vaccines' Interview by Hans van Maanen

Nederlands tijdschrift voor geneeskunde, 2007-01, Vol.151 (1), p.66

Rümke, Hans

2007

Volltextzugriff (PDF)

Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine

Vaccine, 2006-04, Vol.24 (15), p.2781-2789

2006

Volltextzugriff (PDF)

Improved body weight and performance status and reduced serum PGE2 levels after nutritional intervention with a specific medical food in newly diagnosed patients with esophageal cancer or adenocarcinoma of the gastro‐esophageal junction

Journal of cachexia, sarcopenia and muscle, 2015-03, Vol.6 (1), p.32-44

2015

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(49)

Sprache

Englisch
(45)
Niederländisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(40)
Science & Technology
(35)
Life Sciences & Biomedicine
(34)
Female
(22)
Immunology
(21)
Infectious Diseases
(21)
Male
(21)
Biological And Medical Sciences
(20)
Medical Sciences
(17)
Vaccines
(16)
Child, Preschool
(15)
Medicine, Research & Experimental
(15)
Research & Experimental Medicine
(15)
Vaccination
(14)
Fundamental And Applied Biological Sciences. Psychology
(12)
Immunization
(12)
Infant
(12)
Microbiology
(12)
Child
(11)
Vaccines, Antisera, Therapeutical Immunoglobulins And Monoclonal Antibodies
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands

Safety and immunogenicity of an MF59® -adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age

Varicella vaccination in Europe - taking the practical approach

Adverse events and association with age, sex and immunological parameters of Q fever vaccination in patients at risk for chronic Q fever in the Netherlands 2011

Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax®) in individuals aged ≥ 70 years: A randomized study of a single dose vs. two different two-dose schedules

The epidemiology of varicella and herpes zoster in The Netherlands: Implications for varicella zoster virus vaccination

Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children

Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial

Immunogenicity and tolerability of an MF59-adjuvanted, egg-derived, A/H1N1 pandemic influenza vaccine in children 6-35 months of age

Safety of a 2-dose regimen of a combined measles, mumps, rubella and varicella live vaccine manufactured with recombinant human albumin

Implementation of a Q fever vaccination program for high-risk patients in the Netherlands

Specific Interferon γ Detection for the Diagnosis of Previous Q Fever

Immunization of Early Adolescent Females with Human Papillomavirus Type 16 and 18 L1 Virus-Like Particle Vaccine Containing AS04 Adjuvant

Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2–3 and 7–8 years of age

Elevated Immune Response Among Children 4 Years of Age With Pronounced Local Adverse Events After the Fifth Diphtheria, Tetanus, Acellular Pertussis Vaccination

Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial

The burden of varicella from a parent's perspective and its societal impact in The Netherlands: an Internet survey

In Memoriam: Prof. Dr. J.M.J.J. Vossen (1937–2019)

A tailor‐made approach for causality assessment for ADR reports on drugs and vaccines

Prevention of Meningococcal Serogroup B Infections in Children: A Protein-Based Vaccine Induces Immunologic Memory

Reactogenicity of acellular pertussis vaccine in 4-year-olds in The Netherlands

Vaccine-Induced Antibody Responses as Parameters of the Influence of Endogenous and Environmental Factors

'Without industry no vaccines' Interview by Hans van Maanen

Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine

Improved body weight and performance status and reduced serum PGE2 levels after nutritional intervention with a specific medical food in newly diagnosed patients with esophageal cancer or adenocarcinoma of the gastro‐esophageal junction

Suchergebnisse filtern